Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins

Mass Spectrometry Reviews

Volumn 23, Issue 4, 2004, Pages 281-305

  Carini, Marina ^a   Aldini, Giancarlo ^a   Facino, Roberto Maffei ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

4 hydroxy trans 2 nonenal; Adduct characterization; Mass spectrometry; Peptide interaction

Indexed keywords

ALDEHYDES; CARDIOVASCULAR SYSTEM; DISEASES; FATTY ACIDS; GENES; IONIZATION; MASS SPECTROMETRY; OXIDATION; POLYPEPTIDES;

4-HYDROXY-TRANS-2-MONEAL; ADDUCT CHARACTERIZATION; MATRIX ASSISTED LASER DESORPTION/IONIZATION (MALDI); PEPTIDE INTERACTION;

PROTEINS;

4 HYDROXYNONENAL; 4-HYDROXY-2-NONENAL; ALDEHYDE; PEPTIDE; PROTEIN;

CHEMISTRY; MASS SPECTROMETRY; METHODOLOGY; REVIEW;

ALDEHYDES; MASS SPECTROMETRY; PEPTIDES; PROTEINS;

EID: 3042596594     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.10076     Document Type: Review

References (86)

1. Alderton AL, Faustman C, Liebler DC, Hill DW. 2003. Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal. Biochemistry 42(15): 4398-4405.
2. Aldini G, Granata P, Carini M. 2002. Detoxification of cytotoxic a, β-unsaturated aldehydes by carnosine: Characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/ mass spectrometry in rat skeletal muscle. J Mass Spectrom 37(12):1219-1228.
3. Aldini G, Carini M, Beretta G, Bradamante S, Maffei Facino R. 2002. Carnosine is a quencher of 4-hydroxy-nonenal: Through what mechanism of action? Biochem Biophys Res Commun 298(5):699-706.
4. Aldini G, Granata P, Orioli M, Santaniello E, Carini M. 2003. Detoxification of 4-hydroxy-nonenal (HNE) in keratinocytes: Characterization of conjugated metabolites by LC-ESI-MS/MS. J Mass Spectrom 38(11):1160-1168.
5. Benedetti A, Comporti M, Esterbauer H. 1980. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 620(2):281-296.
6. Bennaars-Eiden A, Higgins LA, Hertzel AV, Kapphahn RJ, Ferrington DA, Bernlohr DA. 2002. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J Biol Chem 277(52):50693-50702.
7. Bolgar MS, Yang CY, Gaskell SJ. 1996. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J Biol Chem 271(45):27999-28001.
8. Bolgar MS, Gaskell SJ. 1996. Determination of the sites of 4-hydroxy-2-nonenal adduction to protein by electrospray tandem mass spectrometry. Anal Chem 68(10):2325-2330.
9. Boon PJM, Marinho HS, Oosting R, Mulder GJ. 1999. Glutathione conjugation of 4-hydroxy-trans,-2,3-nonenal in the rat in vivo, the isolated perfused liver and erythrocytes. Toxicol Appl Pharmacol 159(3):214-223.
10. Brambilla G, Sciaba L, Faggin P, Maura A, Marinari UM, Ferro M, Esterbauer H. 1986. Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutat Res 171(2-3):169-176.
11. Bruenner BA, Jones AD, German JB. 1994. Maximum entropy deconvolution of heterogeneity in protein modification: Protein adducts of 4-hydroxy-2-nonenal. Rapid Commun Mass Spectrom 8(7):509-512.
12. Bruenner BA, Jones AD, German JB. 1995. Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. Chem Res Toxicol 8(4):552-559.
13. Carini M, Aldini G, Maffei Facino R, Bozzetto L, Ghirardini A. 2002. Detoxification of cytotoxic unsaturated aldehydes in keratinocytes is a GSH-dependent pathway: Inhibition by UVB and protective effect of histidine and cysteine-containing peptides. Preprints of the 22nd IFSCC, Edinburgh 23-26 September 2002, pp 129-143.
14. Chen Q, Esterbauer H, Jurgens G. 1992. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination. Biochem J 288(1):249-254.
15. Chen J, Henderson GI, Freeman GL. 2001. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol 33(11):1919-1927.
16. Cohn JA, Tsai L, Friguet B, Szweda LI. 1996. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: Immunochemical detection in mitochondria exposed to oxidative stress. Arch Biochem Biophys 328(1):158-164.
17. Crabb JW, O'Neil J, Miyagi M, West K, Hoff HF. 2002. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci 11:831-840.
18. Davis DW, Hamilton RF, Holian A. 1997. 4-Hydroxynonenal inhibits interleukin-l β converting enzyme. J Interferon Cytokine Res 17(4):205-219.
19. Del Corso A, Dal Monte M, Vilardo PG, Cecconi I, Moschini R, Banditelli S, Cappiello M, Tsai L, Mura U. 1998. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch Biochem Biophys 350(2):245-248.
20. Doom JA, Petersen DR. 2002. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem Res Toxicol 15(11):1445-1450.
21. Doom JA, Petersen DR. 2003. Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem Biol Interact 143-144:93-100.
22. Eckl PM, Ortner A, Esterbauer H. 1993. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat Res 290(2):183-192.
23. Enoiu M, Herber R, Wennig R, Marson R, Bodaud H, Leroy P, Mitra N, Siest G, Wellman M. 2002. γ-Glutamyltrans-peptidase-dependent metabolism of 4-hydroxynonenal-glutathione conjugate. Arch Biochem Biophys 397(1):18-27.
24. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 11(1):81-128.
25. Faustman C, Liebler DC, McClure TD, Sun Q. 1999. α,β- unsaturated aldehydes accelerate oxyhemoglobin oxidation. J Agric Food Chem 47(8):3140-3144.
26. Fenaille F, Guy PA, Tabet JC. 2003. Study of protein modification by 4-hydroxy-2-nonenal and other short chain aldehydes analyzed by Electrospray Ionization Tandem Mass Spectrometry. J Am Soc Mass Spectrom 14(3):215-226.
27. Fenaille F, Tabet JC, Guy PA. 2002. Immunoaffinity purification and characterization of 4-hydroxy-2-nonenal- and malon-dialdehyde-modified peptides by Electrospray Ionization Tandem Mass Spectrometry. Anal Chern 74(24):6298-6304.
28. Gardner HW, Deighton N. 2001. Effect of 4-hydroxy-2(E)-nonenal on soybean lipoxygenase. Lipids 36(6):623-628.
29. Grace JM, MacDonald TL, Roberts RJ, Kinter M. 1996. Determination of site-specific modifications of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal using matrix assisted laser desorption time-of-flight mass spectro-metry. Free Radic Res 25(1):23-29.
30. Guichardant M, Taibi-Tronche P, Fay LB, Lagarde M. 1998. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Rad Biol Med 25(9):1049-1056.
31. Hansen BT, Jones JA, Mason DE, Liebler DC. 2001. SALSA: A pattern recognition algorithm to detect electrophile-adducted peptides by automated evaluation of CID spectra in LC-MS-MS analyses. Anal Chem 73(8):1676-1683.
32. Hutchens TW, Yip TT. 1993. New desorption strategies for the mass-spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 7(7):576-580.
33. Ishii T, Tatsuda E, Kumazawa S, Nakayama T, Uchida K. 2003. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 42(12):3474-3480.
34. Issaq HJ, Conrads TP, Prieto DA, Tirumalai R, Veenstra TD. 2003. SELDI-TOF MS for diagnostic proteomics. Anal Chem 75(7):148A-155A.
35. Itakura K, Oya-Ito T, Osawa T, Yamada S, Toyokuni S, Shibata N, Kobayashi M, Uchida K. 2000. Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore. FEBS Lett 473(2):249-253.
36. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. 1997. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17(13):5089-5100.
37. Kuo CL, Vaz ADN, Coon MJ. 1997. Metabolic activation of trans-4-hydroxy-2-nonenal, a toxic product of membrane lipid peroxidation and inhibitor of P450 cytochromes. J Biol Chem 272(36):22611-22616.
38. Laurent A, Perdu-Durand E, Alary J, Debrauwer L, Cravedi JP. 2000. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol Lett 114(1-3):203-214.
39. Lee SH, Blair IA. 2000. Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem Res Toxicol 13(8):698-702.
40. Levine RL, Garland D, Oliver CN, Amid A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478.
41. Li CJ, Nanji AA, Siakotos AN, Lin RC. 1997. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease. Hepatology 26(3):650-657.
42. Liu W, Kato M, Akhand AA, Hayakawa A, Suzuki H, Miyata T, Kurokawa K, Hotta Y, Ishikawa N, Nakashima I. 2000. 4-Hydroxynonenal induces a cellular redox status-related activation of caspase cascade for apoptotic cell death. J Cell Sci 113(1):635-641.
43. Loboda AV, Krutchinsky AN, Bromirski M, Ens W, Standing KG. 2000. A tandem of quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: Design and performance. Rapid Commun Mass Spectrom 14(12):1047-1057.
44. Magni F, Galbusera C, Tremolada L, Ferrarese C, Galli Kienle M. 2002. Characterisation of adducts of the lipid peroxidation product 4-hydroxy-2-nonenal and amyloid β-peptides by liquid chromatography/ electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom 16(15):1485-1493.
45. Medzihradszky KF, Campbell JM, Baldwin MA, Falick AM, Juhasz P, Vestal ML, Burlingame AL. 2000. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal Chem 72(3):552-558.
46. Millar AH, Leaver CJ. 2000. The cytotoxic lipid peroxidation product, 4-hydroxy-2-nonenal, specifically inhibits decarboxylating dehydrogenases in the matrix of plant mitochondria. FEES Lett 481(2):117-121.
47. Mitchell AE, Morin D, Lame MW, Jones AD. 1995. Purification, mass spectrometric characterization, and covalent modification of murine glutathione S-transferases. Chem Res Toxicol 8(8):1054-1062.
48. Musatov A, Carroll CA, Liu YC, Henderson GI, Weintraub ST, Robinson NC. 2002. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 41(25): 8212-8220.
49. Nadkarni DV, Sayre LM. 1995. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem Res Toxicol 8(2):284-291.
50. Pan J, Chung FL. 2002. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions. Chem Res Toxicol 15(3): 367-372.
51. Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU. 1999. 4-Hydroxynonenal as a biological signal: Molecular basis and pathophysiological implications, Antiox Redox Signal-ling 1(3):255-284.
52. Patel MS, Korotchkina L. 2002. Pyruvate dehydrogenase complex as a marker of mitochondrial metabolism inhibition by 4-hydroxy-2-nonenal. Methods Mol Biol 186:255-263.
53. Person MD, Monks TJ, Lau SS. 2003. An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS. Chem Res Toxicol 16(5):598-608.
54. Poli G, Schaur J, 2000. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50(4-5):315-321.
55. Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J, Esterbauer H. 1985. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J 227(2): 629-638.
56. Reinheckel T, Nedelev B, Prause J, Augustin W, Schulz HU, Lippert H, Halangk W. 1998. Occurrence of oxidatively modified proteins: An early event in experimental acute pancreatitis. Free Radic Biol Med 24(3):393-400.
57. Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. 1997. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 322(1):317-325.
58. Sangvanich P, Mackness B, Gaskell SJ, Durrington P, Mackness M. 2003. The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein. Biochem Biophys Res Commun 300(2):501-506.
59. Sayre LM, Arora PK, lyer RS, Salomon RG. 1993. Pyrrole formation from 4-hydroxynonenal and primary amines. Chem Res Toxicol 6(1):19-22.
60. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 1997. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68(5):2092-2097.
61. Schneider C, Tallman KA, Porter NA, Brash AR. 2001. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem 276(24):20831-20838.
62. Shevchenko A, Loboda A, Shevchenko A, Ens W, Standing KG. 2000. MALDI quadrupole time-of-flight mass spectrometry: A powerful tool for proteomic research. Anal Chem 72(9):2132-2141.
63. Srivastava S, Dixit BL, Cai J, Sharma S, Hurst HE, Bhatnagar A, Srivastava SK. 2000. Metabolism of lipid peorxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: Role of aldose reductase. Free Rad Biol Med 29(7):642-651.
64. Stanyer L, Betteridge DJ, Smith CC. 2002. An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis. FEES Lett 518(1-3): 72-78.
65. Szweda LI, Uchida K, Tsai L, Statdman ER. 1993. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem 268(5):3342-3347.
66. Tanaka N, Tajima S, Ishibashi A, Uchida K, Shigematsu T. 2001. Immunohistochemical detection of lipid peroxidation products, protein-bound acrolein and 4-hydroxynonenal protein adducts, in actinic elastosis of photodamaged skin. Arch Dermatol Res 293(7):363-367.
67. Terman A. 2001. Garbage catastrophe theory of aging: Imperfect removal of oxidative damage? Redox Report 6(1):15-26.
68. Traverso N, Menini S, Cosso L, Odetti P, Albano E, Pronzato MA, Marinari UM. 1998. Immunological evidence for increased oxidative stress in diabetic rats. Diabetologia 41(3):265-270.
69. Uchida K. 2000. Role of reactive aldehyde in cardiovascular diseases. Free Rad Biol Med 28(12):1685-1696.
70. Uchida K. 2003.4-Hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res 42(4):318-343.
71. Uchida K, Stadtman ER. 1992a. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci USA 89(10):4544-4548.
72. Uchida K, Stadtman ER. 1992b. Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal. Proc Natl Acad Sci USA 89(12):5611-5615.
73. Uchida K, Stadtman ER. 1993. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J Biol Chem 268(9):6388-6393.
74. Uchida K, Szweda LI, Chae H, Stadtman ER. 1993. Immuno-chemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci USA 90: 8742-8746.
75. Uchida K, Toyokuni S, Nishikawa K, Oda H, Hiai H, Stadtman ER. 1994. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: Markers for atherosclerosis. Biochemistry 33(41):12487-12494.
76. Uchida K, Itakura K, Kawakishi S, Hiai H, Toyokuni S, Stadtman ER. 1995. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch Biochem Biophys 324(2):241-248.
77. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. 1999. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274(4):2234-2242.
78. Van Kuijk FJGM. 1997. 4-Hydroxynonenal interaction with rhodopsin. Biochem Biophys Res Commun 230(2):275-279.
79. Vander Jagt DL, Hunsaker LA, Vander Jagt TJ, Gomez MS, Gonzales DM, Deck LM, Royer RE. 1997. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol 53(8):1133-1140.
80. Véronneau M, Comte B, Des Rosiers C. 2002. Quantitative gas chromatographic-mass spectrometric assay of 4-hydroxy-nonenal bound to thiol proteins in ischemic/reperfused rat hearts. Free Rad Biol Med 33(10):1380-1388.
81. Waeg G, Dimsity G, Esterbauer H. 1996. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 25(2):149-159.
82. Wilm M, Neubauer G, Mann M. 1996. Parent ion scans of unseparated peptide mixtures. Anal Chem 68(3):527-533.
83. Ylä-Hertuuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84(4):1086-1095.
84. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93(7):2696-2701.
85. Zheng H, Ojha PC, McClean S, Black ND, Hughes JG, Shaw C. 2003. Heuristic charge assignment for deconvolution of Electrospray Ionization mass spectra. Rapid Commun Mass Spectrom 17(5):429-436.
86. Zhou S, Decker EA. 1999. Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products. J Agric Food Chem 47(1): 51-55.